Next Article in Journal
A Cost–Utility Analysis of Atezolizumab in the Second-Line Treatment of Patients with Metastatic Bladder Cancer
Previous Article in Journal
Age-Dependent Increased Odds of Cardiovascular Risk Factors in Cancer Survivors: Canadian Longitudinal Study on Aging Cohort
 
 
Article

No Article Versions Notes Found

Back to TopTop